Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • chariko
    Member
    • Jun 2010
    • 56

    #1

    RnaSeq vs Microarray correlation

    Hi all,

    I have an experiment with 80 samples both of them run with microarray and RnaSeq. I want to correlate the results between the two technologies.

    I received the results from the RnaSeq experiment in two ways:

    a) Raw data (fastq files)
    b)Table of ensembl id´s counts (no idea how this analysis was done).

    I did the analysis in two ways:

    1)
    For the RnaSeq experiment I took the ensembl id´s counts, translated them into Gene Symbol identifiers (various ensembl Id`s derived in the same Gene Symbol so I just used one of them randomly selected and the other ensembl id´s were discarded), and normalized them with voom (log2 with some modifications).

    For the Microarray experiment I normalized them (RMA) using a curated database (hgu133plus2hsentrezgcdf). I translated the entrez id´s probes into Gene Symbol identifiers.

    I did the correlation between microarray and RnaSeq (cor.test, two sides, spearman method)) and I obtained good results for all the samples (07-0.9). Attached figure 1 with the scatterplot of sample 1.

    2)
    I took the fastq files and analyzed them taking into account the HG19 GRC 37 RefSeq as reference. I translated the refseq id´s into gene symbol. I randomly selected one gene symbol per refseq id.

    Same microarray data was used for the correlation.

    I did the same correlatin as before but the results were worse (0.3-48). Figure 2 shows scatterplot of sample 1.

    My question is, does anybody have a clue about why starting with refseq id´s is not giving the same good results? Any clues?

    Thanks in advance.
    Attached Files

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
17 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
33 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Working...